How much does it cost to take Ituzumab/Ointuzumab (Besponsa)?

Besponsa oxalican Leukemia, B-ALL). It is a monoclonal antibody drug whose mechanism of action is to interfere with the growth and survival of leukemia cells by targeting the CD22 antigen on the surface of lymphocytes.

Ogaintozumab/Ointozumab has been launched in China, but it is not included in medical insurance. The domestic price is around 60,000 to 70,000 yuan, which is very expensive. Patients can buy it domestically. There are only original drugs available abroad, mainly Pfizer’s original drugs, which cost more than 80,000 yuan.

B-ALL is a rare but severe type of leukemia that usually occurs in adults, especially those who have become resistant to traditional treatments or have relapsed. Oplusintuzumab/The introduction of intuzumab provides a new treatment option for these patients.

The course of treatment with oxinuximab/oxinuximab is usually supervised and managed by a medical professional. Common adverse reactions to the drug include fever, infection, anemia, bleeding tendencies, and nausea. TreatmentB-ALLusually requires a comprehensive treatment strategy, including a combination of multiple drugs, bone marrow transplantation, and supportive therapy to help patients achieve long-term remission.

Importantly, patients should consult their physician or healthcare professional for the latest treatment guidelines and individualized treatment options before using oxinuximab/oxinuximab or any other medicine. Treating leukemia is a complex process that requires precise diagnosis and treatment planning based on the patient's specific circumstances.